ArticleNature nanotechnology2024
AI-nano-driven surface-enhanced Raman spectroscopy for marketable technologies.
Article in Nature nanotechnology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed.
- Non-Invasively Quantitative Raman Imaging for Calculation of Lymphatic Transport Kinetics of Micelles in Mice.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Article
- Seeing Beyond RGB Capabilities: Data-Driven and Physics-Guided Broadband Spectral Extrapolation of Plasmonic Nanostructures by Deep Learning.ACS photonics · 2026Article
- Transforming Paper into Plasmonic Sensors: One-Step Fabrication of High-Enhancement SERS Nanosubstrates via Surface Energy Control.Small methods · 2026Article
- Protocol for cerebrospinal fluid analysis using enrichment-enhanced surface-enhanced Raman spectroscopy and transformer-enabled spectral classification.STAR protocols · 2026Article
- Next-Generation SERS Probes: Engineering Hotspots, Intelligent Molecular Targeting, and AI-Driven Spectral Analysis for Emerging Applications.Nanomaterials (Basel, Switzerland) · 2026Review
- Understanding SERS Spectral Shape Variability through Substrate Optics, Molecular Orientation, and Unsupervised Clustering.The journal of physical chemistry. C, Nanomaterials and interfaces · 2026Article
- Quantitative Surface-Enhanced Raman Spectroscopy: Challenges, Strategies, and Prospects.Molecules (Basel, Switzerland) · 2026Review
- From nanotags to precision biomedicine: SERS-driven progress and innovation in tumor biomarker profiling, dynamic bioimaging, AI-enhanced diagnostics and therapy.Theranostics · 2026Review
- Rapid hyperspectral Raman imaging of cells with depthwise separable 3D MultiResU-Net.iScience · 2025Article
- SERS-AI-LUA-Driven Salivary Diagnosis of Head and Neck Cancer Using Graphene-Assisted Plasmonic Nanocorals.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025Article
- SERS Cheminformatics: Opportunities for Data-Driven Discovery and Applications.ACS central science · 2025Review
- Surface-enhanced Raman spectroscopy as a tool for food and environmental monitoring of pesticides: recent trends and perspectives.Nanoscale advances · 2025Review
- Rapid and sensitive acute leukemia classification and diagnosis platform using deep learning-assisted SERS detection.Cell reports. Medicine · 2025Article
- Direct On-Analyte Fabrication of Au Nanoparticles for Substrate-Free SERS Detection of Micro and Nanoplastics.ACS omega · 2025Article
- Review
- Multiplex Detection and Quantification of Virus Co-Infections Using Label-free Surface-Enhanced Raman Spectroscopy and Deep Learning Algorithms.ACS sensors · 2025Article
- Raman Spectroscopy of Fullerenes: From CMolecules (Basel, Switzerland) · 2025Review
- Hot-spot empowered gold nanoparticles for theranostics in breast cancer.Theranostics · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
PubMed holds no abstract for this paper.
Identifiers
39639177What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.